Prospective study of strongyloidosis in patients with hematologic malignancies.

15Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Immunocompromised individuals infected with Strongyloides stercoralis may develop severe hyperinfection or disseminated disease with high mortality. Patients with hematological malignancies are at risk because of immunodepression produced either by the disease or its treatment. A prospective study was undertaken at the Hospital de Clínicas de Porto Alegre, from July 1994 to July 1995. Seventy-two (HIV negative), had 3 stool samples collected at different days and had not received recent anthelmintic therapy. Larvae, isolated in a modified Baermann method, were found in 6 patients, with a resultant prevalence of 8.3%. No complicated strongyloidosis was documented. The positive result for S. stercoralis larvae was significantly associated (p < 0.001) with eosinophilia. Knowledge of prevalence figures and incidence of severe disease is important to adequate guidelines for empirical treatment besides the rigorous search for strongyloidosis in patients with hematological malignancies.

Cite

CITATION STYLE

APA

Graeff-Teixeira, C., Leite, C. S., Sperhacke, C. L., Fassina, K., Petry, S. M., Mucenic, T., … Job, F. (1997). Prospective study of strongyloidosis in patients with hematologic malignancies. Revista Da Sociedade Brasileira de Medicina Tropical, 30(5), 355–357. https://doi.org/10.1590/S0037-86821997000500001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free